New shot could help kids and adults fight off infections
Disease control
Recruiting now
This study tests a new antibody replacement therapy (BP-SCIG 20%) given as a weekly injection under the skin. It aims to see if it is safe and effective at preventing serious infections in people with primary immunodeficiency, a condition where the immune system cannot produce en…
Phase: PHASE3 • Sponsor: Biopharma Plasma LLC • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC